Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
335
-
Total 13F shares, excl. options
-
35.8M
-
Shares change
-
-163K
-
Total reported value, excl. options
-
$7.31B
-
Value change
-
+$15.7M
-
Put/Call ratio
-
1.17
-
Number of buys
-
149
-
Number of sells
-
-176
-
Price
-
$204.11
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q3 2018
381 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q3 2018.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 335 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.8M shares
of 152M outstanding shares and own 23.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.77M shares), Vanguard Group Inc (3.36M shares), BROWN CAPITAL MANAGEMENT LLC (2.07M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.6M shares), Neuberger Berman Group LLC (1.53M shares), BAMCO INC /NY/ (1.51M shares), JANUS HENDERSON GROUP PLC (1.39M shares), Mairs & Power INC (1.17M shares), STATE STREET CORP (971K shares), and WELLINGTON MANAGEMENT GROUP LLP (948K shares).
This table shows the top 335 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.